Vahab Vahdat
Overview
Explore the profile of Vahab Vahdat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alcock R, Shaukat A, Kisiel J, Hernandez L, Delarmente B, Estes C, et al.
Health Aff Sch
. 2025 Mar;
3(3):qxaf041.
PMID: 40078452
The substantial carbon footprint imparted by medical services warrants increased attention to their environmental impact. National guideline organizations such as the US Preventive Services Task Force (USPSTF) recommend multiple modalities...
2.
Alagoz O, May F, Doubeni C, Fendrick A, Vahdat V, Estes C, et al.
J Natl Cancer Inst
. 2024 Jul;
116(11):1807-1816.
PMID: 39044335
Background: The benefits of colorectal cancer (CRC) screening programs rely on completing follow-up colonoscopy when a noncolonoscopy test is abnormal and on quality of colonoscopy screening as measured by the...
3.
Kisiel J, Fendrick A, Ebner D, Ozbay A, Vahdat V, Estes C, et al.
J Med Econ
. 2024 Apr;
27(1):746-753.
PMID: 38686394
Objective: This analysis estimated the outcomes of triennial blood-based colorectal cancer (CRC) screening at various adherence, including perfect adherence, compared with triennial multi-target stool DNA (mt-sDNA) screening at the reported...
4.
Ebner D, Finney Rutten L, Miller-Wilson L, Markwat N, Vahdat V, Ozbay A, et al.
Cancer Prev Res (Phila)
. 2024 Apr;
17(6):275-280.
PMID: 38561018
Prevention Relevance: This retrospective study highlights the importance of convenient stool-based colorectal cancer screening options to achieve the national goal of 80% for overall colorectal cancer screening rates. Empowering screening-eligible...
5.
Ebner D, Kisiel J, Fendrick A, Estes C, Li K, Vahdat V, et al.
JAMA Netw Open
. 2024 Mar;
7(3):e245537.
PMID: 38551567
No abstract available.
6.
Fendrick A, Kisiel J, Brooks D, Vahdat V, Estes C, Ebner D, et al.
Popul Health Manag
. 2023 Nov;
26(6):448-450.
PMID: 37930304
No abstract available.
7.
Fendrick A, Lieberman D, Chen J, Vahdat V, Ozbay A, Limburg P
Cancer Res Commun
. 2023 Oct;
3(10):2113-2117.
PMID: 37787758
Significance: A follow-up colonoscopy after a positive stool-based colorectal cancer screening test is necessary to complete the full screening process. Policies that remove cost barriers to completing colorectal cancer screening...
8.
Ebner D, Kisiel J, Barnieh L, Sharma R, Smith N, Estes C, et al.
J Med Econ
. 2023 Sep;
26(1):1219-1226.
PMID: 37752872
Aim: The United States Preventive Services Taskforce (USPSTF) recently recommended lowering the age for average-risk colorectal cancer (CRC) screening from 50 to 45 years. While initiating screening at age 45...
9.
Fendrick A, Vahdat V, Chen J, Lieberman D, Limburg P, Ozbay A, et al.
Popul Health Manag
. 2023 Jul;
26(4):239-245.
PMID: 37466476
The Centers for Medicare & Medicaid Services (CMS) recommend covering blood-based tests meeting proposed minimum performance thresholds for colorectal cancer (CRC) screening. Outcomes were compared between currently available stool-based screening...
10.
Vahdat V, Alagoz O, Chen J, Saoud L, Borah B, Limburg P
Med Decis Making
. 2023 Jul;
43(6):719-736.
PMID: 37434445
Objectives: Machine learning (ML)-based emulators improve the calibration of decision-analytical models, but their performance in complex microsimulation models is yet to be determined. Methods: We demonstrated the use of an...